Baseline characteristics | No. of studies | No. of eyes | Study heterogeneity | Analysis model | Analysis of the pooled data | ||
---|---|---|---|---|---|---|---|
I2, % | P value | WMD (95Â % CI) | P value | ||||
Duration of symptoms | 3 | 125 | 0 | 0.69 | fixed-effects | −0.05 (−0.50, 0.39) | 0.82 |
Refractive error | 6 | 180 | 46 | 0.10 | fixed-effects | 0.85 (−0.13, 1.83) | 0.09 |
Axial length | 5 | 132 | 18 | 0.30 | fixed-effects | −0.34 (−1.04, 0.37) | 0.35 |
Preoperative BCVA | 4 | 150 | 0 | 0.88 | fixed-effects | 0.08 (−0.04, 0.20) | 0.19 |